Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancerMan Luo(North Sichuan Medical University), Xiaolan Guo(Affiliated Hospital of North Sichuan Medical College)Frontiers in PharmacologyDecember 16, 202510.3389/fphar.2025.1689663Cited by 0SaveCiteExport RISWatch citationsRelated PapersRETRACTED: The PI3K/mTOR dual inhibitor NVP‐BEZ235 stimulates mutant p53 degradation to exert anti‐tumor effects on triple‐negative breast cancer cells|FEBS Open Bio|2020|29Expression and functional analyses of TERF2 in esophageal carcinoma|Heliyon|2024|1